“2017 APEC International Healthcare Summit” was held recently in Diaoyutai State Guesthouse. During the summit, Beijing Rogrand E-Commerce Co., Ltd. (hereinafter referred to as “Beijing Rogrand”) announced its completion of the RMB 380 million Series C1 financing. This round of financing was led by Ping An Ventures and Healthcare Fund of HG Partners under HG Capital; and Trustbridge Partners and Fosun RZ Capital also made investment therein. It is one of the largest financing in the digital medical service industry.

Zhifang Lu and Xiaoyan Liu, partners of East & Concord Partners Beijing Office, represented Beijing Rogrand and provided legal services for this round of financing from the beginning to the end, including but not limited to drafting, reviewing and negotiating about the trading documents, and assisting the company and each and every party in completing the delivery.

Beijing Rogrand now serves nearly a hundred medical industrial enterprises, over 1,500 medical business companies, 150,000 drugstores, medical establishments and grassroots clinics. Its online trading volume reached RMB 22.4 billion in 2016, and is the only drug supply chain platform covering the whole industrial chain and 30 provinces nationwide. The platform trading volume will break through RMB 50 billion in 2017.

This firm started to provide legal services for Beijing Rogrand early 2015, and assisted Beijing Rogrand in completing Series A, Series B and Series C1 financing. Moreover, as the legal counsel of Beijing Rogrand, this firm is also responsible for providing legal services for and controlling the compliance of Beijing Rogrand’s business cooperation with pharmaceutical enterprises, medical institutions and financial enterprises, and for completing Beijing Rogrand’s investments abroad and equity acquisition projects.